Homology Medicines Revenue and Competitors
Estimated Revenue & Valuation
- Homology Medicines's estimated annual revenue is currently $3.7M per year.
- Homology Medicines's estimated revenue per employee is $26,667
- Homology Medicines's total funding is $187M.
- Homology Medicines's current valuation is $210.9M. (January 2022)
Employee Data
- Homology Medicines has 138 Employees.
- Homology Medicines grew their employee count by -25% last year.
Homology Medicines's People
Name | Title | Email/Phone |
---|---|---|
1 | Employee Engagement Specialist & Office Manager | Reveal Email/Phone |
2 | Scientist I | Reveal Email/Phone |
Homology Medicines Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $12.7M | 82 | -45% | $107.3M | N/A |
#2 | $0.2M | 1 | -50% | N/A | N/A |
#3 | $6.2M | 40 | 21% | N/A | N/A |
#4 | $42.2M | 218 | 4% | $165M | N/A |
#5 | $14.6M | 94 | -37% | $312.8M | N/A |
#6 | $0.3M | 2 | -67% | N/A | N/A |
#7 | $235M | 366 | -5% | $340.9M | N/A |
#8 | $56M | 289 | -7% | $7.6M | N/A |
#9 | $4.7M | 61 | 36% | N/A | N/A |
#10 | $2M | 13 | 8% | N/A | N/A |
What Is Homology Medicines?
Homology Medicines is a genetic medicines company translating proprietary gene editing and gene therapy technologies into novel treatments for patients with rare diseases.
keywords:N/A$187M
Total Funding
138
Number of Employees
$3.7M
Revenue (est)
-25%
Employee Growth %
$210.9M
Valuation
N/A
Accelerator
Homology Medicines News
2022-04-17 - Homology Medicines Announces Promotion of Albert ...
BEDFORD, Mass., April 21, 2022 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today...
2022-04-17 - Homology Medicines Announces Promotion of Albert ...
BEDFORD, Mass., April 21, 2022 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $40M | 138 | 7% | N/A |
#2 | $40.3M | 139 | 0% | N/A |
#3 | $42.2M | 142 | 46% | N/A |
#4 | $40.2M | 144 | 12% | N/A |
#5 | $39.2M | 145 | 4% | N/A |